GenVault room temperature archive system enables the storage, extraction, retrieval and exchange of DNA samples paired with clinically relevant information mined and stored in GenConnect software
GRI (Genetic Research Instrumentation), an independent supplier of biotechnology products, has signed an exclusive distribution agreement with GenVault.
The agreement enables GRI to represent GenVault's biosample management systems in the UK, French and Irish biotechnology research sectors.
GenVault is a supplier of integrated biosample management systems and consumables.
GenVault manufactures DNA storage and archiving focused on revolutionising conventional DNA storage techniques with a room temperature archive system that enables the storage, extraction, retrieval and exchange of DNA samples paired with clinically relevant information mined and stored in the associated GenConnect software.
GenVault products are applicable to medical, academic, pharmaceutical and forensic institutions.
As a scalable and reliable alternative to traditional freezer networks and DNA purification systems, GenVault's dry-state platform enables the extraction, preservation and recovery of DNA at room temperature.
This novel sample management is configured for each customer's workflow and the planned growth of their biosample archive.
From its GenPlate to its Dynamic Archive, GenVault says it is continuously developing and refining best practices for integrated biosample management.
GenPlates are the core of GenVault's system, eliminating the need for freezers and liquid nitrogen tanks while maintaining biosamples in a stable format suitable for long term archiving, automated retrieval and simplified distribution.
The 384 well GenPlate contains 6mm disc-shaped elements of Whatman FTA paper in each well, allowing biosamples to be stored at room temperature.
Each element within the GenPlate is an experiment-sized aliquot that can be removed without risk of cross-contamination or sample degradation from multiple freeze-thaw cycles.
The basic GenPlate is configured to hold a sample across 384 aliquots and requires about 4ml of biological fluid such as blood, buffy coat, cell suspensions, buccal mouthwash or even already purified genomic DNA to fill the entire plate.
The sample is applied directly to each element within the GenPlate and allowed to dry.
Cells within the sample lyse upon contact with the FTA material and the extruded DNA binds avidly to the cellulose matrix.
The GenPlate is sealed and is ready for short or long-term archiving.
FTA inactivates bacteria and viruses upon contact, allowing samples to be easily shipped without any biohazard labelling.
DNA stored on FTA paper as long as 14 years ago has been recovered in sufficient quantity and quality for current genotyping techniques.
Once a sample is applied to a GenPlate, an indisputable chain of custody is established.
Each GenPlate is labelled with a unique physical barcode and each element within the GenPlate is labelled with GenCode (also unique to each GenPlate), GenVault's biological barcode, which permanently identifies the actual sample regardless of its physical state.
GRI's teams of sales executives will promote, supply and support GenVault's various product lines with immediate effect within the UK, France and Ireland.
